These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 26768099

  • 1. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
    Bing AU, Kerr GR, Jack W, Chetty U, Williams LJ, Rodger A, Dixon JM.
    Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective axillary node sampling and radiotherapy to the axilla in the management of breast cancer.
    Tanguay JS, Ford DR, Sadler G, Buckley L, Uppal H, Cross J, Holmes N, Fortes Mayer K, Fernando I.
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):677-82. PubMed ID: 18722758
    [Abstract] [Full Text] [Related]

  • 5. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, Győrffy B, Kásler M, Mátrai Z.
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [Abstract] [Full Text] [Related]

  • 6. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
    Intra M, Trifirò G, Galimberti V, Gentilini O, Rotmensz N, Veronesi P.
    Br J Surg; 2007 Oct; 94(10):1216-9. PubMed ID: 17583891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [Abstract] [Full Text] [Related]

  • 9. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A, Chamorey E, Ferrero JM, Hannoun-Lévi JM.
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335
    [Abstract] [Full Text] [Related]

  • 12. Axillary radiotherapy in conservative surgery for early-stage breast cancer (stage I and II).
    García Novoa A, Acea Nebril B, Díaz I, Builes Ramírez S, Varela C, Cereijo C, Mosquera Oses J, López Calviño B, Seoane Pillado MT.
    Cir Esp; 2016 Apr 01; 94(6):331-8. PubMed ID: 27256280
    [Abstract] [Full Text] [Related]

  • 13. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F, Fourquet A.
    J Clin Oncol; 2004 Jan 01; 22(1):97-101. PubMed ID: 14701770
    [Abstract] [Full Text] [Related]

  • 14. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.
    de Boniface J, Frisell J, Bergkvist L, Andersson Y, Swedish Breast Cancer Group and the Swedish Society of Breast Surgery.
    Br J Surg; 2017 Feb 01; 104(3):238-247. PubMed ID: 28052310
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q.
    Zhonghua Zhong Liu Za Zhi; 2013 Mar 01; 35(3):207-11. PubMed ID: 23880002
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
    Sanuki N, Takeda A, Amemiya A, Ofuchi T, Ono M, Ogata H, Yamagami R, Hatayama J, Eriguchi T, Kunieda E.
    Clin Breast Cancer; 2013 Feb 01; 13(1):69-76. PubMed ID: 23062706
    [Abstract] [Full Text] [Related]

  • 20. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J, Cody H, Tan L, Morrow M, Hudis C, Catalano J, McCormick B, Powell S, Ho A.
    Cancer; 2012 Apr 15; 118(8):1994-2003. PubMed ID: 21882186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.